Author

Nilüfer Yıldırım

Observed names: Nilufer Yildirim, Nilufer Yıldirim, Yildirim, Nilufer, yıldırım, nilüfer

Institution: Acıbadem University

Observed institutions: Acıbadem University, Amerikan Hastanesi

ORCID: 0000-0002-9201-8552

Observed ORCID: 0000-0002-9201-8552

OpenAlex ID: A5001503347

Abstract PS01-01: Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study

2024 · Neslihan Cabıoğlu, Hasan Karanlik, et al. · Cancer Research · 2

Prepectoral Direct-to-Implant Breast Reconstruction Without Acellular Dermal Matrice or Mesh: A Prospective Single-Surgeon Series of 210 Patients and 349 Breasts

2026 · Burcu Celet Ozden, Gamze Aytaş Sevindik, et al. · Aesthetic Surgery Journal

Factors Predicting Additional Residual Nodal Disease With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy

2025 · Neslihan Cabıoğlu, Hasan Karanlık, et al. · Journal of Breast Cancer

Combined Analysis of the MF18-02/03 Neosentiturk Studies: Factors Predicting Recurrence in ycN0/ypN-positive Breast Cancer with Sentinel Lymph Node Biopsy - Or Targeted Axillary Dissection - Alone After Neoadjuvant Chemotherapy

2023 · ŞENOL, KAZIM, Ozmen, Vahit, et al. · Bursa Uludag University - AVESIS

Abstract PD15-01: PD15-01 AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03

2023 · Neslihan Cabıoğlu, Hasan Karanlik, et al. · Cancer Research

Primer Meme Kanserli Hastalarda, F-18 FDG PET/BTGörüntülemedeki Metabolik Parametrelerin Histopatolojikve İmmünohistokimyasal Prognostik Faktörler ileKorelasyonu

2018 · KULAÇOĞLU, SEZER, TÜRKÖLMEZ, ŞEYDA, et al. · AYBU AVESIS

Works count: 6

Citation count: 2

H-index: 1

I10-index: